AAM Urges Congress To Re-evaluate Blocking Act
Report Claims Legislation Could Cost $1.7bn For Each Generic Delayed
Pointing out the “critical shortcomings of the Blocking Act” in a new report, the AAM has urged the US Congress to re-evaluate the legislation.
